TNF and serum lipopolysaccharide activity: In summary, these findings suggest that, in a rodent model of laparotomy and endotoxemia, dopexamine at doses within the clinical range can attenuate TNF-α release, tissue leukocyte infiltration, and hence organ injury at doses that do not alter global hemodynamics or regional microvascular flow.